| BCBS Louisiana | Ergotamine/Dihydroergotamine Products | 2026-03-01 |
| BCBS Louisiana | Select Drugs for Attention Deficit Hyperactivity Disorder (ADHD) | 2026-03-01 |
| BCBS Louisiana | emicizumab (Hemlibra®) | 2026-03-01 |
| BCBS Louisiana | baricitinib (Olumiant®) | 2026-03-01 |
| BCBS Louisiana | Qbrexza™ (glycopyrronium) | 2026-03-01 |
| BCBS Louisiana | Nasal Swell Body Ablation Reduction in the Treatment of Nasal Obstruction | 2026-03-01 |
| BCBS Louisiana | Conjupri™ (levamlodipine) | 2026-03-01 |
| BCBS Louisiana | triheptanoin oral liquid (Dojolvi™) | 2026-03-01 |
| BCBS Louisiana | cysteamine ophthalmic solution 0.37% (Cystadrops®) | 2026-03-01 |
| BCBS Louisiana | Brexafemme® (ibrexafungerp) | 2026-03-01 |